Prostate cancer gene therapy and the role of radiation

J M Kaminski1, K Nguyen, M Buyyounouski

  • 1Department of Radiation Oncology, Fox Chase Cancer Center, 7701 Burolme Avenue, Philadelphia, PA 19111, USA. JM_Kaminski@FCCC.edu

Insights

Gene therapy offers a promising new approach for treating prostate cancer, especially when combined with radiation. Further research into gene therapy and prostate cancer biology could lead to improved treatment options.

Area of Science:

  • Oncology
  • Molecular Biology
  • Radiotherapy

Background:

  • Prostate cancer remains a leading cause of cancer mortality in American men, despite earlier detection.
  • Current therapies are insufficient for high-risk localized and metastatic prostate cancer.
  • New therapeutic strategies are actively being investigated.

Purpose of the Study:

  • To explore gene therapy as a novel treatment modality for prostate cancer.
  • To evaluate the potential of gene therapy in combination with radiation therapy.

Main Methods:

  • Review of existing research on gene therapy for prostate cancer.
  • Analysis of in vivo studies investigating the efficacy of gene therapy combined with radiation.

Main Results:

  • Gene therapy has shown potential as a treatment for both localized and systemic prostate cancer.
  • Gene therapy demonstrated supra-additive effects with radiation in controlling prostate cancer in vivo.

Conclusions:

  • Gene therapy is an emerging and promising therapeutic option for prostate cancer.
  • The combination of advanced radiation therapy and gene therapy holds significant potential for future prostate cancer treatment.
  • Continued advancements in understanding prostate cancer biology will further enhance the role of gene therapy.

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...